FDA Asks GSK, Others For Data On Asthma Drugs

Law360, New York (March 6, 2008, 12:00 AM EST) -- The U.S. Food and Drug Administration has requested additional information from several asthma-drug makers, including GlaxoSmithKline and Novartis AG, in order to conduct further review of the drugs' safety.

The FDA said in a statement Wednesday that it asked the drugmakers in January for information about controlled clinical studies conducted on the products, known as long-acting beta agonists.

The drugs the agency has requested information on are GlaxoSmithKline's Advair and Serevent, Novartis AG's Foradil, AstraZeneca's Symbicort, Mylan Inc.'s Perforomist and Sepracor Inc.'s Brovana.

The companies indicated...
To view the full article, register now.